MedTrace Logo

Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects

NCT02264054 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2014-10-15

No results posted yet for this study

Summary

Study to investigate metabolism, pharmacokinetic, safety and tolerability of talsaclidine.

Conditions

  • Healthy

Interventions

DRUG

[14C]talsaclidine, oral

DRUG

[14C]talsaclidine, iv

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-02-28
Primary Completion
1999-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264054 on ClinicalTrials.gov